Mayo Clinic proceedings
-
Mayo Clinic proceedings · Nov 2024
Observational StudySafety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease: A Target Trial Emulation.
To evaluate the safety of triptans in migraine patients with cardiovascular disease or elevated cardiovascular risk. ⋯ Triptans likely increase the risk of MACE; however, the incidence of MACE remains low in migraine patients with cardiovascular disease or elevated cardiovascular risk.